Adrenal Incidentalomas: Insights Into Prevalence
Authors: Irina Bancos
Journal: Annals of Internal Medicine (2022)

EditorialsOctober 2022Adrenal Incidentalomas: Insights Into PrevalenceIrina Bancos, MDIrina Bancos, MDMayo Clinic, Rochester, MinnesotaAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/M22-2600 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail The incidence of adrenal tumors has increased 10-fold over the past 2 decades, in parallel to the growing number of computed tomography (CT) abdominal scans (1). The observed increase in the incidence of adrenal tumors was mainly due to more frequent discovery of smaller adrenal incidentalomas in older patients (1). However, because an abdominal CT scan is usually ordered to evaluate a medical concern, imaging bias is very likely in any prevalence study that relies on the availability of imaging (1–5). Another concern is underreporting of adrenal lesions noted on CT scans. For example, Hammarstedt and colleagues (3) reported that ...References1. Ebbehoj A, Li D, Kaur RJ, et al. Epidemiology of adrenal tumours in Olmsted County, Minnesota, USA: a population-based cohort study. Lancet Diabetes Endocrinol. 2020;8:894-902. [PMID: 33065059] doi:10.1016/S2213-8587(20)30314-4 CrossrefMedlineGoogle Scholar2. Cyranska-Chyrek E, Szczepanek-Parulska E, Olejarz M, et al. Malignancy risk and hormonal activity of adrenal incidentalomas in a large cohort of patients from a single tertiary reference center. Int J Environ Res Public Health. 2019;16. [PMID: 31137898] doi:10.3390/ijerph16101872 CrossrefMedlineGoogle Scholar3. Hammarstedt L, Muth A, Wängberg B, et al; Adrenal Study Group of Western Sweden. Adrenal lesion frequency: a prospective, cross-sectional CT study in a defined region, including systematic re-evaluation. Acta Radiol. 2010;51:1149-56. [PMID: 20969508] doi:10.3109/02841851.2010.516016 CrossrefMedlineGoogle Scholar4. Ichijo T, Ueshiba H, Nawata H, et al. A nationwide survey of adrenal incidentalomas in Japan: the first report of clinical and epidemiological features. Endocr J. 2020;67:141-152. [PMID: 31694993] doi:10.1507/endocrj.EJ18-0486 CrossrefMedlineGoogle Scholar5. Reimondo G, Castellano E, Grosso M, et al. Adrenal incidentalomas are tied to increased risk of diabetes: findings from a prospective study. J Clin Endocrinol Metab. 2020;105. [PMID: 31900474] doi:10.1210/clinem/dgz284 CrossrefMedlineGoogle Scholar6. Jing Y, Hu J, Luo R, et al. Prevalence and characteristics of adrenal tumors in an unselected screening population. A cross-sectional study. Ann Intern Med. 2022;175:1383-91. doi:10.7326/M22-1619 LinkGoogle Scholar7. Bancos I, Taylor AE, Chortis V, et al; ENSAT EURINE-ACT Investigators. Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study. Lancet Diabetes Endocrinol. 2020;8:773-781. [PMID: 32711725] doi:10.1016/S2213-8587(20)30218-7 CrossrefMedlineGoogle Scholar8. Prete A, Subramanian A, Bancos I, et al; ENSAT EURINE-ACT Investigators. Cardiometabolic disease burden and steroid excretion in benign adrenal tumors. A cross-sectional multicenter study. Ann Intern Med. 2022;175:325-334. [PMID: 34978855] doi:10.7326/M21-1737 LinkGoogle Scholar9. Stavropoulos K, Imprialos KP, Katsiki N, et al. Primary aldosteronism in patients with adrenal incidentaloma: is screening appropriate for everyone. J Clin Hypertens (Greenwich). 2018;20:942-948. [PMID: 29722113] doi:10.1111/jch.13291 CrossrefMedlineGoogle Scholar10. Fassnacht M, Arlt W, Bancos I, et al. Management of adrenal incidentalomas: European Society of Endocrinology clinical practice guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol. 2016;175:G1-G34. [PMID: 27390021] doi:10.1530/EJE-16-0467 CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: Mayo Clinic, Rochester, MinnesotaDisclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M22-2600.Corresponding Author: Irina Bancos, MD, Division of Endocrinology, Diabetes, and Nutrition, Mayo Clinic, 200 First Street SW, Rochester, MN 55905; e-mail, bancos.[email protected]edu.This article was published at Annals.org on 13 September 2022. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoPrevalence and Characteristics of Adrenal Tumors in an Unselected Screening Population Ying Jing , Jinbo Hu , Rong Luo , Yun Mao , Zhixiao Luo , Mingjun Zhang , Jun Yang , Ying Song , Zhengping Feng , Zhihong Wang , Qingfeng Cheng , Linqiang Ma , Yi Yang , Li Zhong , Zhipeng Du , Yue Wang , Ting Luo , Wenwen He , Yue Sun , Fajin Lv , Qifu Li , and Shumin Yang Metrics Cited byPossible, probable, and certain hypercortisolism: A continuum in the risk of comorbidityMost incidentally found adrenal tumours are non-functioning, regardless of age, study finds October 2022Volume 175, Issue 10Page: 1481-1482KeywordsAdrenal tumors ePublished: 13 September 2022 Issue Published: October 2022 Copyright & PermissionsCopyright © 2022 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...